We appreciate your patience. Your content is on the way.
SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Aarti Pharmalabs Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity `Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date. Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023. 9,06,26,008 Equity Shares of Rs 5/- each got listed effective January 30, 2023.
Aarti Pharmalabs share price as on 16 May 2025 is Rs. 795.25. Over the past 6 months, the Aarti Pharmalabs share price has increased by 20.98% and in the last one year, it has increased by 28.67%. The 52-week low for Aarti Pharmalabs share price was Rs. 497.05 and 52-week high was Rs. 837.25.
543748
AARTIPHARM
INE0LRU01027
Aug
Aarti Pharmalabs Ltd FAQs
You can buy Aarti Pharmalabs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarti Pharmalabs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 15, 2025 04:06 PM the closing price of Aarti Pharmalabs Ltd was Rs.795.25.
The latest PE ratio of Aarti Pharmalabs Ltd as of May 15, 2025 04:06 PM is 26.49
The latest PB ratio of Aarti Pharmalabs Ltd as of May 15, 2025 04:06 PM is 0.28
The 52-week high of Aarti Pharmalabs Ltd share price is Rs. 837.25 while the 52-week low is Rs. 497.05
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 15, 2025 04:06 PM, the market cap of Aarti Pharmalabs Ltd stood at Rs. 7,207.75 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.